BRCA1 Mut+ Ovarian Cancer
Epithelial ovarian cancer accounts for approximately 90 percent of all cases of ovarian cancer. Common mutations found in epithelial ovarian cancer include BRCA1, BRCA2, and TP53. Common over expressions include cyclin E1, Rsf-1, and fatty acid synthases. High grade serous ovarian cancer (HGSC) accounts for approximately 70% of epithelial ovarian cancers, and BRCA1 mutations are more uncommon than TP53 mutations and are found in about 13% of HGSC cases. HGSC has the highest incident rates as well as the lowest survival rates among subtypes of ovarian cancer. BRCA1 mutations present in the ovarian cancer phenotype are sometimes heritable. According to new research many of HGSC cancer cells are thought to originate in the fallopian tubes and are thought to migrate to the ovaries and implant there. The function of the protein encoded by the BRCA1 gene is well characterized as a tumor suppressor. On the contrary, although TP53 mutations are very common in ovarian cancers and TP53 is known to be a tumor suppressor as well, the role of its mutants in leading to a cancerous phenotype is not well understood. A study showed no phenotypic differences between a mutant TP53 and a TP53 knockout, so the BRCA1 mutation is of immediate interest.
Recent comments